#######################
# Document Properties #
#######################

SET DOCUMENT Licenses    = "MIT License"
SET DOCUMENT ContactInfo = "farah.humayun@scai-extern.fraunhofer.de"

SET DOCUMENT Name        = "heme_30324533.bel"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Farah Humayun"
SET DOCUMENT Description = "Heme BEL model is a disease model based on Biological Expression Language (BEL) containing the core mechanisms of heme as modulator in Hemolytic diseases such as sickle-cell anemia, beta-thalassemia, malaria and autoimmune hemolytic anemia."

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE CTO            AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE SCOMP          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns"
DEFINE NAMESPACE SFAM           AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

DEFINE NAMESPACE HM        AS PATTERN ".*"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------

DEFINE ANNOTATION Species       AS PATTERN ".*"
DEFINE ANNOTATION TimePoint     AS PATTERN ".*"
DEFINE ANNOTATION Concentration     AS PATTERN ".*"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############

SET Citation = {"PubMed", "Mol Cell Biochem. 2018 Oct 15. doi: 10.1007/s11010-018-3452-3.", "30324533"}

SET TextLocation = "Introduction"

SET Evidence = "Serum albumin (SA) can act as the heme scavenger by
forming heme-SA complex [2, 4–8]."

SET Species = "Bos taurus"
p(HGNC:ALB) -| a(CHEBI:heme)

SET Evidence = "For this reason, it has
been considered as a therapeutic tool to counteract heme
toxic effects in severe hemolytic diseases, and the usefulness
of SA therapy has already been demonstrated in a rat model
of acute intracerebral hematoma [2, 9]."

SET MeSHDisease = "Hematoma"
p(RGD:Alb) -| path(HM:"Heme cytotoxicity")

SET Evidence = "HSA
was found to be the major target of oxidative stress in
hemodialysis patients [18] and its cysteine34 residue was
revealed to works as a free radical scavenger in patients
with sepsis syndrome [19]."

SET TextLocation = "Results"

SET Evidence = "Whereas at the doses of 3, 4, and 5 μM,
heme significantly reduced the viability of cells, which was
in agreement with an earlier study [1]."

a(CHEBI:heme) neg bp(MESH:"Cell Survival")

SET Evidence = "The result showed that cell viability loss
in a GO dose-dependent manner, and 1.5 mU mL−1 GO
induced approximately 15% cell death after 24 h of treatment
(Fig. 2b)."

a(MESH:"Glucose Oxidase") neg bp(MESH:"Cell Survival")

SET Evidence = "As illustrated in Fig. 2d, the
loss of viability by heme/H2O2 and heme/H2O2/NO2
− was
approximately 53 ± 3.8% and 65 ± 4.5%, respectively, which
further confirmed that NO2
− dramatically enhances heme/
H2O2 toxicity.This result is well consistent with previous
reports [3, 13]."

complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide")) neg bp(MESH:"Cell Survival")
complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite)) neg bp(MESH:"Cell Survival")

SET Evidence = "As shown in Fig. 2d, heme/H2O2/
NO2−-induced loss of cell viability was significantly attenuated
by BSA or BSA-T pretreatment, and BSA was more
effective than BSA-T."

p(HGNC:ALB) pos bp(MESH:"Cell Survival")
p(HGNC:ALB, pmod(Ph, Tyr)) pos bp(MESH:"Cell Survival")

SET Evidence = "Apoptosis has been found to be a major rout for the elimination
of cells after a variety of stresses including ROS
and RNS [30]."

a(MESH:"Reactive Oxygen Species") pos bp(MESH:Apoptosis)
a(MESH:"Reactive Nitrogen Species") pos bp(MESH:Apoptosis)

SET Evidence = "Figure 3a depicts the morphology of SHSY5Y
cells after treated with various conditions. Compared
with heme/H2O2 treatment, cells exposing to heme/
H2O2/NO2
− exacerbated cell apoptotic and reduced cell
yield."

complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite)) pos bp(MESH:Apoptosis)

SET Evidence = "However, pretreatment
with 2 μM BSA or BSA-T, we found that both
BSA and BSA-T efficiently inhibited heme/H2O2/NO2
−-
induced cell apoptotic and increased cell yields."

p(HGNC:ALB) -| act(complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite)))
p(HGNC:ALB, pmod(Ph, Tyr)) -| act(complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite)))
p(HGNC:ALB) neg bp(MESH:Apoptosis)
p(HGNC:ALB, pmod(Ph, Tyr)) neg bp(MESH:Apoptosis)

SET Evidence = "As quantified
in Fig. 3c, although heme/H2O2/NO2
− increased the
apoptotic rate to 32 ± 6.4%, BSA or BSA-T pretreatment
caused a statistically significant reduced apoptotic rate
(10 ± 5.0% and 15 ± 6.1%, respectively)."

complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite)) pos bp(MESH:Apoptosis)
p(HGNC:ALB) neg bp(MESH:Apoptosis)
p(HGNC:ALB, pmod(Ph, Tyr)) neg bp(MESH:Apoptosis)

SET Evidence = "Malondialdehyde (MDA)
represents evidence of systemic oxidative stress and
inflammation [31], and is commonly used to estimate the
level of lipid peroxidation."

a(CHEBI:malonaldehyde) pos bp(MESH:"Oxidative Stress")
a(CHEBI:malonaldehyde) pos path(MESH:Inflammation)
a(CHEBI:malonaldehyde) pos bp(MESH:"Lipid Peroxidation")

SET Evidence = "The carbonyl contents (Fig. 4a)
and MDA level (Fig. 4c) from heme/H2O2/NO2
−-treated
cells were the highest under all conditions."

complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite))

SET Evidence = "The carbonyl contents (Fig. 4a)
and MDA level (Fig. 4c) from heme/H2O2/NO2
−-treated
cells were the highest under all conditions."

complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite)) pos a(CHEBI:"carbonyl group")
complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite)) pos a(CHEBI:malonaldehyde)

SET Evidence = "Both BSA and
BSA-T attenuated heme/H2O2/NO2
−-induced protein carbonylation
and lipid peroxidation."

p(HGNC:ALB) -| bp(MESH:"Protein Carbonylation")
p(HGNC:ALB, pmod(Ph, Tyr)) -| bp(MESH:"Protein Carbonylation")
p(HGNC:ALB) -| bp(MESH:"Lipid Peroxidation")
p(HGNC:ALB, pmod(Ph, Tyr))-| bp(MESH:"Lipid Peroxidation")

SET Evidence = "Protein tyrosine nitration has been identified as a biomarker
of oxidative stress, and the generation of 3-nitrotyrosine
(3-NT) is often accompanied with the increasing of ROS and
RNS under pathologic condition [14]."

a(CHEBI:"3-nitrotyrosine") pos a(MESH:"Reactive Oxygen Species")
a(CHEBI:"3-nitrotyrosine") pos a(MESH:"Reactive Nitrogen Species")

SET Evidence = "As shown in Fig. 5a,
significant amount of 3-NT emerged in cultures following
heme/H2O2/NO2
− treatment for 24 h (red staining), indicating
the strongest nitrative stress level."

complex(a(CHEBI:heme), a(CHEBI:"hydrogen peroxide"), a(CHEBI:nitrite)) pos a(CHEBI:"3-nitrotyrosine")

SET Evidence  = "Of note,
incubation with BSA or BSA-T for 24 h decreased heme/
H2O2/NO2
−-derived 3-NT deposits as compared with heme/
H2O2/NO2
− treatment alone, and BSA is more effective on
suppressing the formation of 3-NT than BSA-T (Fig. 5b)."

p(HGNC:ALB) -| a(CHEBI:"3-nitrotyrosine")
p(HGNC:ALB, pmod(Ph, Tyr)) -| a(CHEBI:"3-nitrotyrosine")

SET TextLocation = "Discussion"

SET Evidence = "Monzani et al.
[10] also concluded that the heme-SA complex promotes
H2O2
activation processes that bear the characteristics of
enzymatic reactions and may have biological relevance."

complex(a(CHEBI:heme), p(HGNC:ALB)) -> act(a(CHEBI:"hydrogen peroxide"))

SET Evidence = "This result suggested that tyrosine
residues of BSA may play an important role in heme
detoxification."

p(HGNC:ALB, var("tyr")) -| path(HM:"Heme cytotoxicity")

SET Evidence = "Furthermore, the cytoprotective effect of
BSA was stronger than that of BSA-T (Fig. 5), suggesting
that tyrosine residues of BSA act as oxidation target to
prevent other important protein from heme-induced RNS associated
damage."

p(HGNC:ALB, var("tyr")) -| act(a(MESH:"Reactive Nitrogen Species"))

UNSET TextLocation 
##########

